Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06558981 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

NCT06558981 · ClinicalTrials.gov record · last posted 2026-02-27

Adjuvant Radiotherapy in High Risk Locally Advanced DTC

Name: Adjuvant Radiotherapy in High Risk Locally Advanced DTC — clinical trial record (NCT06558981)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusRecruiting

PhasePhase 3

SponsorFudan University

Started2024-07-11

View on ClinicalTrials.gov ↗

from the ClinicalTrials.gov record

This study is a phase III randomized controlled clinical trial on the role of adjuvant radiotherapy in high-risk locally advanced differentiated thyroid cancer. Patients who meet the inclusion criteria were randomly assigned 1:1 to either the experimental group (adjuvant radiotherapy+RAI) or the control group (RAI), with LRFS as the primary endpoint of the study.

Amendment record 1 amendment on the ClinicalTrials.gov record

This ClinicalTrials.gov record has been amended once since 2024-08-14. DataLookout shows field-level changes from the day a trial enters its daily monitoring; earlier amendments are counted here from the ClinicalTrials.gov version history. See every version on ClinicalTrials.gov ↗

Trial Details

NCT Number	NCT06558981
Lead Sponsor	Fudan University
Conditions	Thyroid Cancer
Enrollment	124 participants
Start Date	2024-07-11
Primary Completion	2031-06 (estimated)
Study Completion	2031-06 (estimated)
Updated on ClinicalTrials.gov	2026-02-27